MAPT allele and haplotype frequencies in Nigerian Africans: Population distribution and association with Parkinson's disease risk and age at onset
- PMID: 37467655
- DOI: 10.1016/j.parkreldis.2023.105517
MAPT allele and haplotype frequencies in Nigerian Africans: Population distribution and association with Parkinson's disease risk and age at onset
Abstract
Introduction: The association between MAPT and PD risk may be subject to ethnic variability even within populations of similar geographical origin. Data on MAPT haplotype frequencies, and its association with PD risk in black Africans are lacking. We aimed to determine the frequencies of MAPT haplotypes and their role as risk factors for PD and age at onset in Nigerians.
Methods: The haplotype and genotype frequencies of MAPT rs1052553 were analysed in 907 individuals with PD and 1022 age-matched healthy controls from the Nigeria Parkinson's Disease Research network cohort. Clinical data related to PD included age at study, age at onset (AAO), and disease duration.
Results: The frequency of the H1 haplotype was 98.7% in PD, and 99.1% in controls (p = 0.19). The H2 haplotype was present in - 1.3% of PD and 0.9% of controls (p = 0.24). The most frequent MAPT genotype was H1H1 (PD - 97.5%, controls - 98.2%). The H1 haplotype was not associated with PD risk after accounting for gender and AAO (Odds ratio for H1/H1 vs H1/H2 and H2/H2: 0.68 (95% CI:0.39-1.28); p = 0.23).
Conclusions: Our findings support previous studies that report a low frequency of the MAPT H2 haplotype in black ancestry Africans but document its occurrence in Nigerians. The MAPT H1 haplotype was not associated with an increased risk or age at onset of PD in this cohort.
Keywords: Africa; Black ancestry; Genetics; H1 haplotype; H2 haplotype; MAPT; Nigeria; Parkinson's disease.
Copyright © 2023. Published by Elsevier Ltd.
Conflict of interest statement
Declaration of competing interest R.A. is supported by the following grants: US NIH/NHGRI (U01HG010273) and the UK Royal Society/African Academy of Sciences (FLR/R1/191813). M.R. received funding from the University College London Grand challenges Small Grants (Award ID:177813 and the Michael J Fox Foundation Genetic Diversity in Parkinson's Disease 2019 (Grant ID:17483). H.H. is supported by the Michael J Fox Foundation Genetic Diversity in Parkinson's Disease (Grant ID: 17483). N.U.O. is supported by the Michael J Fox Foundation Genetic Diversity in Parkinson's Disease 2019 (Grant ID:17483) and the TETFund National Research Fund (NRF) 2019. S.B.-C., C.B. and A.S. are supported by the Intramural Research Program, National Institute on Aging, National Institutes of Health and US Department of Health and Human Services project ZO1 AG000949 and all these authors declare no non-financial competing interests. The remaining authors declare no competing interests.
Update of
-
MAPT allele and haplotype frequencies in Nigerian Africans: population distribution and association with Parkinson's disease risk and age at onset.medRxiv [Preprint]. 2023 Mar 24:2023.03.24.23287684. doi: 10.1101/2023.03.24.23287684. medRxiv. 2023. Update in: Parkinsonism Relat Disord. 2023 Aug;113:105517. doi: 10.1016/j.parkreldis.2023.105517. PMID: 36993627 Free PMC article. Updated. Preprint.
Similar articles
-
MAPT allele and haplotype frequencies in Nigerian Africans: population distribution and association with Parkinson's disease risk and age at onset.medRxiv [Preprint]. 2023 Mar 24:2023.03.24.23287684. doi: 10.1101/2023.03.24.23287684. medRxiv. 2023. Update in: Parkinsonism Relat Disord. 2023 Aug;113:105517. doi: 10.1016/j.parkreldis.2023.105517. PMID: 36993627 Free PMC article. Updated. Preprint.
-
H1/H2 MAPT haplotype and Parkinson's disease in Mexican mestizo population.Neurosci Lett. 2019 Jan 18;690:210-213. doi: 10.1016/j.neulet.2018.10.029. Epub 2018 Oct 16. Neurosci Lett. 2019. PMID: 30339920
-
Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue.Acta Neuropathol Commun. 2023 Mar 11;11(1):40. doi: 10.1186/s40478-023-01534-9. Acta Neuropathol Commun. 2023. PMID: 36906636 Free PMC article.
-
MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies.Alzheimers Dement. 2016 Dec;12(12):1297-1304. doi: 10.1016/j.jalz.2016.05.002. Epub 2016 Jun 7. Alzheimers Dement. 2016. PMID: 27287057 Free PMC article. Review.
-
Meta-analysis of the association between variants in MAPT and neurodegenerative diseases.Oncotarget. 2017 Jul 4;8(27):44994-45007. doi: 10.18632/oncotarget.16690. Oncotarget. 2017. PMID: 28402959 Free PMC article. Review.
Cited by
-
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2024 Update.J Parkinsons Dis. 2024;14(5):899-912. doi: 10.3233/JPD-240272. J Parkinsons Dis. 2024. PMID: 39031388 Free PMC article. Review.
-
Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study.Lancet Neurol. 2023 Nov;22(11):1015-1025. doi: 10.1016/S1474-4422(23)00283-1. Epub 2023 Aug 23. Lancet Neurol. 2023. PMID: 37633302 Free PMC article.
-
Unraveling the complex role of MAPT-containing H1 and H2 haplotypes in neurodegenerative diseases.Mol Neurodegener. 2024 May 29;19(1):43. doi: 10.1186/s13024-024-00731-x. Mol Neurodegener. 2024. PMID: 38812061 Free PMC article. Review.
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical